Safety of BA.4-5 or BA.1 bivalent mRNA booster vaccines: nationwide cohort study
Description
CONCLUSIONS: The use of bivalent mRNA vaccines as a fourth vaccine dose against covid-19 was not associated with an increased risk of 27 different adverse events in adults aged ≥50 years.
